Nov 17 (Reuters) - Centene Corp CNC.N :
* EVOLENT HEALTH ANNOUNCES ACQUISITION OF SPECIALTY ASSET
NIA AND
STRATEGIC PARTNERSHIP WITH CENTENE
* EVOLENT HEALTH INC- TRANSACTION ANTICIPATED TO BE
IMMEDIATELY
ACCRETIVE TO ADJUSTED EBITDA MARGINS AND CASH FLOW
* EVOLENT HEALTH INC- BELIEVE EXPANSIONS WILL GENERATE AT
LEAST
$20 MILLION OF ADJUSTED EBITDA BY Q4 OF 2024
* EVOLENT-IN ADDITION TO NIA ACQUISITION,CO & CENTENE ARE
EXPANDING CENTENE'S RELATIONSHIP WITH NIA, EXTENDING NIA'S
CONTRACTS WITH CENTENE THROUGH 2027
* EVOLENT HEALTH INC- WILL ACQUIRE NIA FROM CENTENE FOR $650
MILLION OF UPFRONT CONSIDERATION
* EVOLENT HEALTH INC- COMPANY EXPECTS TO FUND $400 MILLION
OF
PURCHASE PRICE IN CASH
* EVOLENT HEALTH INC - ANTICIPATES 2023 REPORTED REVENUE
GROWTH TO
EXCEED 25% BEFORE ANY IMPACT FROM NIA
Source text for Eikon: ID:nPn9x2Znda
Further company coverage: CNC.N
((Reuters.Briefs@thomsonreuters.com;))